Home > Insider Trading > Filing (0000899866-14-000204)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
899866	Alexion Pharmaceuticals Inc	ALXN	Pharmaceutical Preparations (2834)	133648318

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1231949	Leonard Bell	C/O Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire CT 06410	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $.0001 Per Share	Acquisiton	2014-09-16	32,047	$17.65	1,053,321	No	4	M	Direct
Common Stock, Par Value $.0001 Per Share	Disposition	2014-09-16	12,878	$159.87	1,040,443	No	4	S	Direct
Common Stock, Par Value $.0001 Per Share	Disposition	2014-09-16	19,169	$160.53	1,021,274	No	4	S	Direct
Common Stock, Par Value $.0001 Per Share	Disposition	2014-09-18	12,388	$161.45	1,008,886	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to Purchase Common Stock	Disposition	2014-09-16	32,047	$0.00	32,047	$17.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2008-04-09	2018-01-09	No	4	M	Direct

Footnotes

This transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $159.15 - $160.15. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $160.15 - $161.50. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
The sale of common stock reported by this Form 4 consists of Alexion common stock contributed by the reporting person to an exchange fund in exchange for shares of the exchange fund. The Alexion shares were valued at $161.45 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.